WO1997048678A1 - Procede de preparation de sels organiques de n'n-diacetylcystine - Google Patents
Procede de preparation de sels organiques de n'n-diacetylcystine Download PDFInfo
- Publication number
- WO1997048678A1 WO1997048678A1 PCT/SE1997/001068 SE9701068W WO9748678A1 WO 1997048678 A1 WO1997048678 A1 WO 1997048678A1 SE 9701068 W SE9701068 W SE 9701068W WO 9748678 A1 WO9748678 A1 WO 9748678A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protonated form
- organic base
- diacetylcystine
- preparation
- alkali metal
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 150000003839 salts Chemical class 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims abstract description 11
- 150000007530 organic bases Chemical class 0.000 claims abstract description 10
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 8
- YTPQSLLEROSACP-YUMQZZPRSA-N (2R)-2-acetamido-3-[[(2R)-2-acetamido-2-carboxyethyl]disulfanyl]propanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CSSC[C@@H](C(O)=O)NC(C)=O YTPQSLLEROSACP-YUMQZZPRSA-N 0.000 claims abstract description 6
- 230000003197 catalytic effect Effects 0.000 claims abstract description 5
- 229960004308 acetylcysteine Drugs 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 12
- 230000003647 oxidation Effects 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-Lysine Natural products NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 235000019766 L-Lysine Nutrition 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims description 3
- 229960003805 amantadine Drugs 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 claims description 3
- 235000018977 lysine Nutrition 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 claims description 2
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 claims 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 claims 1
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- YTPQSLLEROSACP-UHFFFAOYSA-N 2-acetamido-3-[(2-acetamido-2-carboxyethyl)disulfanyl]propanoic acid Chemical compound CC(=O)NC(C(O)=O)CSSCC(C(O)=O)NC(C)=O YTPQSLLEROSACP-UHFFFAOYSA-N 0.000 abstract description 7
- 230000001476 alcoholic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229960003646 lysine Drugs 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- HZRUTVAFDWTKGD-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;hydrate Chemical compound O.NCCCC[C@H](N)C(O)=O HZRUTVAFDWTKGD-JEDNCBNOSA-N 0.000 description 1
- KYNFOMQIXZUKRK-UHFFFAOYSA-N 2,2'-dithiodiethanol Chemical compound OCCSSCCO KYNFOMQIXZUKRK-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 0 C#*C(CNNCC(*#C)N)N Chemical compound C#*C(CNNCC(*#C)N)N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- -1 L-DiNAC Chemical compound 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- LMBWSYZSUOEYSN-UHFFFAOYSA-N diethyldithiocarbamic acid Chemical compound CCN(CC)C(S)=S LMBWSYZSUOEYSN-UHFFFAOYSA-N 0.000 description 1
- 229950004394 ditiocarb Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
- C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
Definitions
- the present invention relates to a new process for the preparation of organic salts of N,N' diacetylcystine [DiNAC].
- N-acetyl-L-cysteine is a well-known compound which is used as a therapeutic agent against chronic obstructive pulmonary diseases and chronic bronchitis.
- L-DiNAC the corresponding disulphide of N-acetyl-L-cysteine, i.e. L-DiNAC, acts as a potent immunostimulator (SE patent appliprotonated form No. 9002067-8), showing an activity comparable to contemporary immunostimulants such as sodium diethyl dithiocarbamate or 2,2'-dithiobisethanol.
- the organic salts described in WO 93/11104 are generally prepared by mixing DiNAC and an organic amine, each dissolved or dispersed in a solvent or solvent mixture. Solvents such as water, alcohols, glycols, ketones, amides, sulphoxides or other polar solvents or solvent mixtures may be used.
- the salt either precipitates directly from the reaction mixture, or is obtained by the addition of a less polar solvent or by evaporation or lyophilisation.
- the salt can be prepared by oxidation of the appropriate N- acetylcysteine salt in an aqueous or alcoholic solution, followed by precipitation as above.
- the oxidation may be effected chemically, using, e.g., hydrogen peroxide or a halogen; alternatively, the oxidation may be effected electrochemically.
- Example 13 in WO 93/11104 describes oxidation of N-acetyl-L-cysteine with hydrogen peroxide in the presence of 1 mole equivalent of sodium hydroxide at a temperature below 10°C, followed by protonation of the product formed with the aid of an activated protonated form exchanger.
- the filtrate is collected, L-lysine is added and di-L-lysinium- N,N'-diacetyl-L-cystinate is crystallised from refluxing ethanol.
- the method involves many steps and is therefore time-consuming. It is important that the temperature during the exothermic oxidation is kept below 25°C, which requires intensive cooling. Otherwise too much decomposition will occur, resulting in a low yield of an impure product.
- Example 19 in WO 93/11104 describes a simpler process for the preparation of di-L- lysinium-N,N'-diacetyl-L-cystinate by dissolving N-acetyl-L-cysteine and L-lysine in deionised water, adding hydrogen peroxide dropwise while stirring and keeping the temperature below 25°C, and stirring the reaction mixture for an additional 4 hours before the product, di-L-lysinium-N.N'-diacetyl-L-cystinate, can be precipitated. This procedure is also time consuming.
- the present invention provides a new process for the preparation of organic salts of DiNAC, the process being faster than the previous methods, generally giving rise to low decomposition and thus purer products. Furthermore, the new process makes it possible to work at relatively high temperatures, thus requiring less cooling during the oxidation reaction.
- the invention provides a process for the preparation of organic salts of N,N' diacetylcystine, having the formulae
- N,N'-diacetylcystine is the D-, L- or meso form, or a mixture thereof
- each of R + and R 2+ is the protonated form of an organic base, preferably selected from lysine, ethylenediamine, N.N'-dibenzylethylene-diamine, adamantanamine, N-benzyl-2- phenylethylamine, piperazine or ammonia.
- the process includes providing a solutioa comprising N-acetyl-L-cysteine, an organic base, a catalytic amount of an alkali metal hydroxide, and a solvent, where the solvent is water or alcohol, and applying an oxidant to the solution.
- a catalytic amount is 0.001 mole equivalents.
- the temperature may be controlled during the oxidation; for example, the temperature may be kept below about 45°C.
- the product may then be precipitated from an alcohol or aqueous alcohol, and isolated.
- a preferred product prepared by the process of the invention is di-L-lysinium-N,N'- diacetyl-L-cystinate.
- the organic salts prepared according to the invention include hydrated and solvated salts, e.g., solvated with lower alkanols.
- catalytic amount is meant a trace amount of alkali metal hydroxide sufficient to catalyse the described reaction; preferably at least 0.001 mole equivalent compared to the N-acetyl-L-cysteine is used, or up to 0.01 or 0.1 mole equivalent. Preferably no more than 0.5 mole equivalent is used. In one embodiment of the invention, about 0.1 mole equivalent of the alkali metal hydroxide is used.
- the temperature during oxidation can be up to the reflux temperature of the chosen solvent, but is preferably up to about 45°C, above which decomposition starts to be noticeable. Below about 5°C, the reaction mixture becomes difficult to stir, and the lower limit for the temperature during oxidation will depend on the stirring equipment. With appropriate stirring equipment, temperatures of below 0°C may be possible, although temperatures of at least 0°C are preferred, more preferably temperatures of 5°C or above.
- Suitable alkali metal hydroxides are, e.g., sodium, potassium or lithium hydroxide.
- the oxidation may be effected either chemically, using, e.g., hydrogen peroxide or halogen as oxidising agent, or electrochemically.
- the salt precipitates directly from the solution or it may be obtained, for example, by the addition of or to a less polar solvent or by evaporation or lyophilisation.
- the process may be aided using crystals of Di-L-lysinium-N,N'-diacetyl-L-cystinate to promote crystallisation.
- the product may be recrystallised for higher purity.
- L-lysine monohydrate 200 kg, 1.0 eq.
- N-acetyl-L-cysteine 200 kg, 1.0 eq.
- potassium hydroxide 6.8 kg, 0.08 eq.
- reaction solution was then added to a refluxing slurry of di-L-lysiniurn-N,N'-diacetyl- L-cystinate (16 kg) in ethanol (2600 L).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32813/97A AU3281397A (en) | 1996-06-18 | 1997-06-17 | Process for the preparation of organic salts of n'n-diacetylcystine |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9602418A SE9602418D0 (sv) | 1996-06-18 | 1996-06-18 | Process for the preparation of organic salts of N'N-diacetylcystine |
SE9602418-7 | 1996-06-18 | ||
SE9602476A SE9602476D0 (sv) | 1996-06-24 | 1996-06-24 | Process for the preparation of organic salts of N'N -diacetylcystine |
SE9602476-5 | 1996-06-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997048678A1 true WO1997048678A1 (fr) | 1997-12-24 |
Family
ID=26662682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1997/001068 WO1997048678A1 (fr) | 1996-06-18 | 1997-06-17 | Procede de preparation de sels organiques de n'n-diacetylcystine |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR007398A1 (fr) |
AU (1) | AU3281397A (fr) |
ID (1) | ID20507A (fr) |
WO (1) | WO1997048678A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993011104A1 (fr) * | 1991-11-29 | 1993-06-10 | Ab Astra | Sels organiques de cystine de n, n'-diacetyle |
-
1997
- 1997-06-04 AR ARP970102430A patent/AR007398A1/es unknown
- 1997-06-09 ID IDP971958A patent/ID20507A/id unknown
- 1997-06-17 AU AU32813/97A patent/AU3281397A/en not_active Abandoned
- 1997-06-17 WO PCT/SE1997/001068 patent/WO1997048678A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993011104A1 (fr) * | 1991-11-29 | 1993-06-10 | Ab Astra | Sels organiques de cystine de n, n'-diacetyle |
Also Published As
Publication number | Publication date |
---|---|
AU3281397A (en) | 1998-01-07 |
ID20507A (id) | 1998-12-31 |
AR007398A1 (es) | 1999-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0208948B1 (fr) | Résolution optique d'un dérivé de l'acide phénylacétique | |
US4963679A (en) | Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes | |
JPS62169755A (ja) | テトラクロロ−2−シアノ安息香酸アルキルエステルの製造方法 | |
WO1997048678A1 (fr) | Procede de preparation de sels organiques de n'n-diacetylcystine | |
CA2451979A1 (fr) | Nouvelles modifications du sel de trometamol de l'acide r-thioctique, ainsi que procedes pour leur production | |
US4212826A (en) | Process for producing cysteamines and/or cystamines | |
CA1313374C (fr) | Procede de fabrication de la pyridazinone | |
JP2001247522A (ja) | 4級アルキルアンモニウムテトラフルオロボレート類の製造方法 | |
KR910003709B1 (ko) | 부틸 3'-(1h-테트라졸-5-일)옥사닐레이트의 제조법 | |
EP1288215B1 (fr) | Procédé de préparation de Famciclovir et prodédé de préparation et cristallisation d' un intermediaire correspondant | |
EP0274194B1 (fr) | Procédé de préparation de 2-nitro-5-phénoxy-N-alcoylsulfonyl-benzamides par nitration | |
JPH075537B2 (ja) | イミノクタジン・3アルキルベンゼンスルホン酸塩の製造方法 | |
JPH0761993B2 (ja) | アジドスルホニル安息香酸の製造法 | |
CA2436265A1 (fr) | Dihydrochlorure d'acide 3-(3-amidinophenyl)-5-[({[1-(1-(-iminoethyl)-4-piperidyl}amino)methyl]benzoique, et procede d'elaboration | |
WO2009019119A1 (fr) | Dérivés du sulfanyle et leur utilisation comme intermédiaires de synthèse | |
US6008413A (en) | Process for recrystallizing 1,3-bis(aminophenoxy benzene) | |
JP3908794B2 (ja) | N−置換不飽和アミドの製造方法 | |
JPH0796537B2 (ja) | 3−(3,4−ジヒドロキシフェニル)セリンの精製方法 | |
JPH06100512A (ja) | ケト酸の製造方法 | |
JP3316917B2 (ja) | 新規フェニルアラニン塩結晶とその製造法 | |
JP2588018B2 (ja) | N―アセチル―6―アミノヘキサン酸誘導体の製造方法 | |
JP2714868B2 (ja) | 2―メチルチオセミカルバジドの製造法 | |
WO2004069817A1 (fr) | Procede ameliore destine a la preparation d'un produit intermediaire de la nizatidine | |
JPS6343382B2 (fr) | ||
WO2003066657A1 (fr) | Processus de preparation de bisulfate d'acide ursodeoxycholique et sels de ce compose repondant aux normes pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 98502800 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |